Management and treatment outcomes of the 41 patients who received antibiotic treatment for M. kansasii lung disease.

Data are presented as numbers (%) or as medians and interquartile ranges.IQR = interquartile ranges; INH = isoniazid; RIF = rifampin; EMB = ethambutol; AZT = azithromycin; CLR = clarithromycin.*The rifampin susceptibility test was performed in 23 patients.**Two patients discontinued medications due to side effects like dyspepsia, anorexia, and urticarial; another patient self-discontinued due to improved respiratory symptoms.†Calculated from the data of 24 patients who completed scheduled treatment.Management and treatment outcomes of the 41 patients who received antibiotic treatment for M. kansasii lung disease.